Share Price, page-3

Normally what happens is with a good result it doesn't go up enough.
and with a bad result it goes down too much.

One needs to remember that we still have retts & fX - which could net us a $680m deal this year (Bell Potter forecast).

But a good positive result should not be down played. $1b US market is there for the taking. With tbi there can be no gene therapies etc, only treatments. If nnz2566 works in tbi I guess it will be the standard treatment for decades. Or maybe until the next nnz drug comes along.

Any tbi treatment that can help the patients will save billions for governments, so it's a no brainer.

I really hope it works. Not just for me, my family, shareholders and the neu team (esp Larry Glass) - but for the poor people who suffer a tbi.

Our drug could be the difference between serious brain damage and mild brain damage, between being able to walk or not, between being able to talk or not, and between life and death.

It will also become the big hope for all chronic brain disorders.

Cheers